Registrations are still coming in for Investment for Advanced Therapies, but you can see a sample of those who will be attending below. If you’re not already down to attend, you can register here.

Job Title Company
Managing Partner 4BIO Capital
Analyst 4BIO Capital Partners
Partner Abingworth
Associate Advent Life Sciences
Director Albion Technology & General VCT plc
Investment Manager – UCL Technology Fund Albion Ventures
Angel Investor Angel Investor
Biotech VC Arix Bioscience
COO Arthrogen
CEO Arthrogen
Principal Astrocyte Consulting
Director Beaufort Sciences/Bonsai Capital
CEO Belsize Asset Management
Consultant BioInsights
Head Biomaterials Group
CEO & CSO Bird-C
Vice President of Immunotherapy bluebird bio
CMO Bone Therapeutics
Professor of Molecular Medicine, National Heart and Lung Institute, Imperial College London & President British Society for Gene and Cell Therapy
Investment Manager Life Science Cambridge Enterprise
Director of Operations Capital Cell
EVP & CSO CARsgen Therapeutics
Corporate VP, Business Development Celgene
Global Head of Transactions & Legal Celixir
Head of Strategy and Planning Cell & Gene Therapy Catapult
CEO Cell Medica
EVP Technical Operations Cellectis
QC Manager Celyad
Director, Biotechnology Business Analyst Clubb Capital
Associate Deep Knowledge Ventures
Syndicate Manager Deepbridge Capital
Investment Advisor DIGAMMA CAPITAL
Biotech Analyst EnsoVentures
Director Regulatory Affairs – Gene and Cell Therapies ERA Consulting Group
Chief Operating Officer ERA Consulting Group
Former Head of Listings Euronext
Venture Partner Fort Rock Capital
Senior Director, Business Development FreeMind Group
Product Marketing Manager GE Healthcare
GM, Cell Therapy Technologies GE Healthcare
Vice President & Head of Gene Therapy Development GlaxoSmithKline
CEO Global Biotherapeutics
Molecular Immunology Unit, UCL Institute of Child Health & Head, Gene Therapy Programme Great Ormond Street Hospital
HIG European Capital
Research & Corporate Broking Hybridan
CEO IDS Capital UK
Director IGALLC
Managing Partner Ignite Capital Partners
CEO Immunicum
Director INKEF Capital
Director, Health and Life Sciences Innovate UK
Director, HipSci Cell Phenotyping King’s College London
Executive Vice President of Technical Operations Kite Pharma
General Partner Kreos Capital
Angel Investor LBA
CSO & GM Lentigen
Angel Investor London Business Angels Syndicate
Chief Scientific Officer, Executive Vice President, Cellular Therapies MaxCyte
VP Strategic Industry Ventures MD Anderson Cancer Center
CFO Medigene
Senior Healthcare Reporter Merger Market
Director Meyer & Co
CEO Nanogenic Solutions
Healthcare Analyst New Science Global Healthcare Fund
CSO New Wave Ventures
Global Pricing & Market Access Director, Cell & Gene Therapies Novartis Pharma AG
Managing Director Novartis Venture Fund
Director of Business Development One Nucleus
CBO Oxford BioMedica (UK) Ltd
CEO Oxford BioMedica (UK) Ltd
Independent Researcher Pangaea
Head, Genetic Medicine Institute; VP Gene Therapy Pfizer
Director Business Development PharmaCell B.V.
Investor Private Investor
CEO PsiOxus Therapeutics
Group CEO & Managing Director ReAya Holding
Director Rothschild
Partner Ruffena Capital
Managing Director RUSNANO Corporation
Medical Director Scottish National Blood Transfusion Service (SNBTS)
Principal Sofinnova Partners
CIO Syncona
Partner Syncona
CEO Synpromics
CEO TC BioPharm
CEO Telocyte
Head of Manufacturing Innovation The Association of the British Pharmaceutical Industry
Chief Executive Officer The Life Sciences Division
Director Healthcare Investments Touchstone Innovations
Venture Partner Touchstone Innovations
VP Scientific Affairs & Business Development TrakCel
CEO TxCell
Lecturer in Translational Neuroscience UCL
Head, Business Intelligence & Innovation Group, Translational Research Office UCL
Senior Research Associate UCL
Director of Cellular Therapeutics & RFH/UCL Cancer Biobank University College London
Director for Entrepreneurship University College London
Professor University of Sheffield
CEO Venture Valuation
CEO ViviaBiotech S.L.
CSO ViviaBiotech S.L.
Managing Director Wharton Asset Management Company
Communications Director Wharton Asset Management Company